NAUTILUS BIOTECH
Nautilus Biotech is a biotechnology company. The company has a pipeline of therapeutic proteins with improved profiles. The company's products include Belerofon, an injectable and orally available interferon alpha for use in the treatment of chronic Hepatitis C infection; and Vitatropin, an injectable and orally available human growth hormone (hGH) for use in the treatment of growth deficiencies. Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company's protein engineering technology improves the pharmacology profile and administration route of blockbuster protein drugs. Nautilus Biotech S.A. was founded in 1999 and is based in Evry, France.
NAUTILUS BIOTECH
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1999-01-01
Address:
Évry, Ile-de-France, France
Country:
France
Total Employee:
11+
Status:
Active
Total Funding:
20.81 M USD
Similar Organizations
Bayhill Therapeutics
Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics.
CureVac
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Investors List
Rothschild & Co.
Rothschild & Co. investment in Venture Round - Nautilus Biotech
Matignon Investissement & Gestion
Matignon Investissement & Gestion investment in Venture Round - Nautilus Biotech
Creabilis
Creabilis investment in Venture Round - Nautilus Biotech
123Venture
123Venture investment in Venture Round - Nautilus Biotech
Auriga Partners
Auriga Partners investment in Venture Round - Nautilus Biotech
Auriga Partners
Auriga Partners investment in Venture Round - Nautilus Biotech
Matignon Investissement & Gestion
Matignon Investissement & Gestion investment in Venture Round - Nautilus Biotech
Andera Partners
Andera Partners investment in Venture Round - Nautilus Biotech
123Venture
123Venture investment in Venture Round - Nautilus Biotech
More informations about "Nautilus Biotech"
Company ~ Nautilus Biotechnology
Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the human proteome. ... where she ultimately led the finance and sales …See details»
Nautilus Biotechnology - LinkedIn
Nautilus Biotechnology | 10,781 followers on LinkedIn. Delivering on the Promise of the Human Proteome | Born from the founders’ recognition that their diverse but complementary skills and ...See details»
Careers ~ Nautilus Biotechnology
When you join Nautilus, you can count on an organization that cares about your well-being and encourages balance. Whether you’re saving for the future, starting a family, practicing self …See details»
Investor Relations | Nautilus Biotechnology Inc.
1 day ago Nautilus Biotechnology seeks to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and …See details»
Nautilus Biotechnology - Crunchbase Company Profile …
Nautilus Biotechnology may be growing as evidenced by their recent financial results and business activities. The company reported its first quarter 2024 financial results, which is a strong indicator of operational activity and potential …See details»
Nautilus Biotechnology Reports First Quarter 2025 Financial
5 days ago Nautilus Biotechnology, Inc. Condensed Consolidated Statements of Operations Three Months Ended March 31, 2025 and 2024 (Unaudited) Three Months Ended March 31, …See details»
News Release Details - Nautilus Biotechnology Inc.
Jun 9, 2021 The combined company, Nautilus Biotechnology, Inc. (“Nautilus”), will commence trading shares of its common stock under the ticker symbol “NAUT” on the Nasdaq Global …See details»
Nautilus Biotechnology: Pioneering a Revolutionary Proteomics …
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. ...See details»
Nautilus Biotechnology Receives Delisting Notice From Nasdaq
6 hours ago NEW YORK – Proteomics firm Nautilus Biotechnology said Friday that it has received notification from the Nasdaq that its common stock bid price has closed below the …See details»
Nautilus Biotech - Crunchbase Company Profile
Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company's protein engineering technology improves the pharmacology profile and administration …See details»
Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript
6 days ago Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ETCompany ParticipantsJi-Yon Yi - Head, Investor...See details»
Nautilus Biotechnology Inc (NAUT) Q1 2025 Earnings Call …
5 days ago Nautilus Biotechnology Inc (NAUT) reports a 13% decrease in operating expenses and maintains a robust cash runway through 2027, while advancing its proteoform assay …See details»
Nautilus Biotechnology - Work in biotech
Nautilus Biotechnology is unlocking the proteome to enable fundamental advances across human health and medicine. There is a wealth of information about human biology that is held within …See details»
Platform ~ Nautilus Biotechnology
The Nautilus Platform employs a methodology called "Protein Identification by Short-Epitope Mapping" (PrISM) for broadscale proteomics and is designed to analyze substantively the …See details»
Nautilus Biotechnology - Funding, Financials, Valuation & Investors
Nautilus Biotechnology is registered under the ticker NASDAQ:NAUT . Nautilus Biotechnology is funded by 15 investors. Ally Bridge Group and Andreessen Horowitz are the most recent …See details»
Next-Gen Proteomics Company Nautilus Biotechnology to List on …
SEATTLE & NEW YORK--(BUSINESS WIRE)--Nautilus Biotechnology, Inc. ("Nautilus Biotechnology" or “Nautilus”), a company pioneering a single-molecule protein analysis …See details»
Nautilus founder unspirals a new approach to proteomics
Sep 21, 2021 Nautilus Biotechnology An artist’s rendering of Nautilus Biotechnology’s platform shows how individual proteins are adsorbed to a chip and repeatedly probed for short amino …See details»
Nautilus Biotechnology Joins Human Proteome Organization
Sep 1, 2022 “Nautilus is looking forward to participating as a Gold Sponsor of the 2022 HUPO World Congress, the premier international conference for proteomics.” About Nautilus …See details»
Nautilus Biotechnology Company Information - Funding, …
Get information on funding, investors, industries, and more for Nautilus Biotechnology. See Nautilus Biotechnology company profile and funding data. Mentioned on: FEATURED IN. …See details»
Resources ~ Nautilus Biotechnology
There are two broad reasons we chose the name Nautilus. This very fitting name gets to: Our goal – to enable voyages of discovery. Much like the Nautilus submarine in 20,000 Leagues Under …See details»